Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Change in Account Payables: 2023-2025

Historic Change in Account Payables for Neurogene (NGNE) over the last 3 years, with Sep 2025 value amounting to -$501,000.

  • Neurogene's Change in Account Payables fell 1627.59% to -$501,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$198,000, marking a year-over-year increase of 60.64%. This contributed to the annual value of -$77,000 for FY2024, which is 111.54% down from last year.
  • As of Q3 2025, Neurogene's Change in Account Payables stood at -$501,000, which was up 48.62% from -$975,000 recorded in Q2 2025.
  • Neurogene's 5-year Change in Account Payables high stood at $1.7 million for Q1 2025, and its period low was -$975,000 during Q2 2025.
  • For the 3-year period, Neurogene's Change in Account Payables averaged around $73,455, with its median value being $27,000 (2023).
  • Examining YoY changes over the last 5 years, Neurogene's Change in Account Payables showed a top increase of 1,154.81% in 2025 and a maximum decrease of 1,627.59% in 2025.
  • Quarterly analysis of 3 years shows Neurogene's Change in Account Payables stood at -$842,000 in 2023, then surged by 50.59% to -$416,000 in 2024, then crashed by 1,627.59% to -$501,000 in 2025.
  • Its last three reported values are -$501,000 in Q3 2025, -$975,000 for Q2 2025, and $1.7 million during Q1 2025.